Trial intelligence / Profile preview

BH-SLP-001 in Menopausal Sleep Disturbance

NCT07375095Completed

Sponsor
Bonafide Health
Start
Oct 2023
Primary completion
Apr 2024
Countries
1
01

Overview

Randomised, double-blind trial in sleep disorder, sponsored by Bonafide Health. Primary endpoints: Patient-Reported Outcomes Measurement Information System Sleep Disturbance Short Form 8b T-score at 3 weeks, Responder Rate for Patient-Reported Outcomes Measurement Information System Sleep Disturbance Short Form 8b at 3 weeks and 2 more. Started Oct 2023; status: completed.

02

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT07375095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07375095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call